Cytokinetics Inc (CYTK)
Receivables turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 18,474 | 7,530 | 94,588 | 70,428 | 55,828 |
| Receivables | US$ in thousands | — | — | — | — | — |
| Receivables turnover | — | — | — | — | — |
December 31, 2024 calculation
Receivables turnover = Revenue ÷ Receivables
= $18,474K ÷ $—K
= —
Based on the provided data, the receivables turnover for Cytokinetics Inc is not available or has been denoted as "—" for the years ending December 31, 2020 to December 31, 2024. Without specific values for the receivables turnover, it is challenging to assess the efficiency of the company in collecting its accounts receivable relative to its sales.
The receivables turnover ratio is a key metric that indicates how quickly a company is able to collect outstanding receivables from its customers. A higher ratio generally suggests that the company is more efficient in collecting its receivables, while a lower ratio may indicate potential issues with collections or credit policies.
In the case of Cytokinetics Inc, the absence of receivables turnover figures makes it difficult to evaluate the company's effectiveness in managing its accounts receivable over the specified time period. It is important for the company to maintain a healthy balance between sales volume and efficient collection practices to ensure timely cash inflows and overall financial health. Additional information or updated data would be necessary to conduct a more thorough analysis of their receivables turnover performance.
Peer comparison
Dec 31, 2024